Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025)
Alvotech (ALVO) posted Net Equity Issued and Repurchased of -$82.4 million for Q3 2025, down 48.28% on a QoQ basis from -$55.6 million in Q2 2025, and up 45.18% year-over-year from -$56.8 million in Q3 2024.
Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends
Alvotech's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$82.4 million for Q3 2025.
- Quarterly Net Equity Issued and Repurchased rose 45.18% year-over-year to -$82.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $150.5 million (up 9.85% YoY) and the FY2023 annual result came in at $136.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$82.4 million for Q3 2025 at Alvotech, down from -$55.6 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $150.5 million in Q4 2024 and bottomed at -$150.3 million in Q3 2024.
- A 3-year average of $42.4 million and a median of $74.6 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased surged 620200.0% — and 2025, when it plunged 548.06%.
- Alvotech's Net Equity Issued and Repurchased stood at $136.9 million in 2023, then grew by 9.92% to $150.5 million in 2024, then tumbled by 154.77% to -$82.4 million in 2025.
- Business Quant data shows ALVO's Net Equity Issued and Repurchased at -$82.4 million in Q3 2025, -$55.6 million in Q2 2025, and $138.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -82.40 Mn |
| Sep 30, 2025 | -82.40 Mn |
| Jun 30, 2025 | -55.57 Mn |
| Jun 30, 2025 | -55.57 Mn |
| Mar 31, 2025 | 138.05 Mn |
| Mar 31, 2025 | 138.05 Mn |
| Dec 31, 2024 | 150.45 Mn |
| Dec 31, 2024 | 150.45 Mn |
| Sep 30, 2024 | -150.30 Mn |
| Sep 30, 2024 | -150.30 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Mar 31, 2024 | 138.05 Mn |
| Mar 31, 2024 | 138.05 Mn |
| Dec 31, 2023 | 136.88 Mn |
| Dec 31, 2023 | 136.88 Mn |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 136.88 Mn |
| Mar 31, 2023 | 136.88 Mn |